Peripherally inserted intravenous cannulas (PIVC) are found in a majority of hospitalised patients. With such widespread use, infections from PIVCs, while infrequent, produce considerable morbidity.
Australian institutions encounter ≥79,000 admissions annually, equating to 94 estimated central or peripheral intravenous access infections, adding $3.28mil in avoidable costs.
Asepsis and antisepsis during placement and maintenance of PIVCs has been a focus for reducing infectious complications. Chlorhexidine has progressively infiltrated the healthcare landscape, but regarding vascular access, is currently recommended only for maintenance antisepsis of arterial and central venous catheters. If discussions supporting Chlorhexidine use for PIVC maintenance are adopted into policy, the number of applications would exponentially increase. Due to the almost ubiquitous presence of Chlorhexidine products, even without a policy shift, their utilisation is likely unknowingly incorporated, regardless. The benefit of using Chlorhexidine in such a widespread application needs to be balanced against the potential risk of an adverse reaction/anaphylaxis, which is still being elucidated.
While there is growing literature linking Chlorhexidine to hypersensitivity reactions, there is no consensus on the clinical significance of intravenous entrainment, nor if PIVC maintenance antisepsis leads to entrainment – although there have been two case reports involving anaphylaxis from Chlorhexidine wipes on PIVC needleless connectors.
The impetus of this study is therefore to provide a methodology for assessing and quantifying Chlorhexidine exposure via the seemingly innocuous process of maintenance antisepsis for needleless connectors.
Royal North Shore Hospital
Dr M Doane, Dr C Kwong, Dr D Healy and Dr S Green.
The project was awarded $42,232 through the ANZCA research grants program in 2018.
In this study the researchers worked with anaesthetists and other experts to develop and refine a set of measures (an “infection prevention bundle”). They used a novel research design to implement this bundle as a quality improvement initiative in five distinct clinical units in random order to look at the effect on the rate of post-operative infection.
The study took four years and included 6,890 surgical operations involving over 400 clinicians. Various factors made the analysis of the results more difficult, notably the advent of the COVID-19 pandemic during our study. Nevertheless, the results strongly suggest that introducing the bundle reduced postoperative infection.
The researchers compared the outcomes of 3,747 patients before implementing this bundle with 3,143 patients after implementing it. They measured its effect on how long patients stay in hospital after surgery and how often they come back to hospital, and how often they got an infection at the site of surgery. Using statistical modelling to account for variations in patient factors and surgical operations it showed that patients spent slightly more days alive and out of hospital after the intervention than before it, and that this was matched by a reduction in the rate of infection. The effect on days alive and out of hospital was more obvious in patients who did less well after surgery – one would not expect a difference in the majority for whom everything went well. Thus the impact of the bundle was greater than the difference in mean DAOH90 would suggest.
The study represented high value for money, with the efficient leverage of secondary data sources enabling the efficient analysis of nearly 7,000 surgical cases on a modest budget relative to other similarly-sized studies (although the generous grant from ANZCA was possibly the largest ever). To achieve this they randomised the order in which the bundles were introduced to sites (distinct clinical units) rather than individual patients. In fact, traditional randomisation would not only have been too expensive, it was also not possible – one could not ask anaethetists to adopt best practice on some patients and then revert to less good practice on subsequent ones.
The interpretation of the results is that there is substantial support for using the bundles to reduce postoperative infection. Taken in conjunction with the limited number of other studies in this area, it is reasonable to conclude that anaesthetists can influence postoperative infection and should increase their already substantia efforts to this end.
Many aspects of the bundles are already accepted as “good practice” and cost nothing. The study strongly reinforces the importance of including these in every anaesthetic. No further evidence is required to justify this.
The role of injecting IV medications through the bacterial filter cannot be ascertained from the study, because it was only one element in the overall bundle of aseptic practices. Given that there is a cost in using these filters, further study evaluating just the filters is now warranted. This could be a traditional randomised clinical trial.
Abstract submission to the ASM was completed at the 2020 ASM, which was cancelled due to the COVID pandemic.
The researchers are working on a full draft for submission to a peer-reviewed journal.
Last modified: